Peter Laufer

453 total citations
20 papers, 347 citations indexed

About

Peter Laufer is a scholar working on Radiology, Nuclear Medicine and Imaging, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, Peter Laufer has authored 20 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pharmaceutical Science and 4 papers in Organic Chemistry. Recurrent topics in Peter Laufer's work include Medical Imaging Techniques and Applications (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Chemical Reactions and Isotopes (6 papers). Peter Laufer is often cited by papers focused on Medical Imaging Techniques and Applications (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Chemical Reactions and Isotopes (6 papers). Peter Laufer collaborates with scholars based in Germany and United States. Peter Laufer's co-authors include G. Stöcklin, K. Wienhard, Wolf‐Dieter Heiss, H.H. Coenen, Stephen M. Moerlein, Walter Wutz, H.‐J. Machulla, Jobst Rudolf, G. Pawlik and Hans‐Jürgen Machulla and has published in prestigious journals such as Life Sciences, European Journal of Nuclear Medicine and Molecular Imaging and Journal of Neural Transmission.

In The Last Decade

Peter Laufer

20 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Laufer Germany 12 192 106 96 52 36 20 347
Hans Svärd Sweden 7 152 0.8× 103 1.0× 67 0.7× 56 1.1× 18 0.5× 10 321
Per Gullberg Sweden 9 212 1.1× 114 1.1× 135 1.4× 61 1.2× 94 2.6× 11 465
Yong‐Woon Jung United States 15 154 0.8× 231 2.2× 110 1.1× 47 0.9× 25 0.7× 27 510
Annika Rimland Sweden 8 178 0.9× 106 1.0× 192 2.0× 59 1.1× 126 3.5× 10 458
D.W. McPherson United States 15 186 1.0× 246 2.3× 167 1.7× 40 0.8× 17 0.5× 44 623
Dean Jolly Canada 13 193 1.0× 97 0.9× 54 0.6× 69 1.3× 30 0.8× 26 423
Johan Ulin Sweden 13 250 1.3× 226 2.1× 158 1.6× 74 1.4× 50 1.4× 27 663
Stéphane Demphel France 11 139 0.7× 152 1.4× 106 1.1× 84 1.6× 35 1.0× 26 376
Louis Tluczek United States 11 123 0.6× 196 1.8× 75 0.8× 35 0.7× 57 1.6× 14 441
Milton M. Perlmutter United States 7 186 1.0× 56 0.5× 100 1.0× 89 1.7× 86 2.4× 8 387

Countries citing papers authored by Peter Laufer

Since Specialization
Citations

This map shows the geographic impact of Peter Laufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Laufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Laufer more than expected).

Fields of papers citing papers by Peter Laufer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Laufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Laufer. The network helps show where Peter Laufer may publish in the future.

Co-authorship network of co-authors of Peter Laufer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Laufer. A scholar is included among the top collaborators of Peter Laufer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Laufer. Peter Laufer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laufer, Peter. (2022). All We Ask Is To Be Left Alone. 1(36). 17–33. 1 indexed citations
2.
Laufer, Peter. (2014). Interviewing: The Oregon Method. 1 indexed citations
3.
Wienhard, K., H.H. Coenen, G. Pawlik, et al.. (1990). PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system. Journal of Neural Transmission. 81(3). 195–213. 41 indexed citations
4.
Coenen, H.H., et al.. (1988). PET measurement of D2 and S2 receptor binding of 3-N-([2?-18F]fluoroethyl)spiperone in baboon brain. European Journal of Nuclear Medicine and Molecular Imaging. 14(2). 80–7. 53 indexed citations
5.
Coenen, H.H., et al.. (1987). 3-N-(2-[18F]-fluoroethyl)-spiperone: A novel ligand for cerebral dopamine receptor studies with pet. Life Sciences. 40(1). 81–88. 49 indexed citations
6.
Moerlein, Stephen M., et al.. (1986). Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 12(4). 211–216. 19 indexed citations
7.
Moerlein, Stephen M., Peter Laufer, & G. Stöcklin. (1985). Effect of Lipophilicity on the in vivo localization of radiolabelled spiperone analogues. International Journal of Nuclear Medicine and Biology. 12(5). 353–356. 26 indexed citations
8.
Moerlein, Stephen M., Peter Laufer, & G. Stöcklin. (1985). Synthesis of no‐carrier‐added radiobrominated N‐alkylated analogues of spiperone. Journal of Labelled Compounds and Radiopharmaceuticals. 22(10). 1007–1022. 13 indexed citations
9.
Laufer, Peter, et al.. (1985). 75,77Br‐Nor‐zimelidine: Radiohalogenation of a complex molecule via a trimethylstannyl precursor. Journal of Labelled Compounds and Radiopharmaceuticals. 22(4). 397–404. 6 indexed citations
10.
Laufer, Peter, et al.. (1984). Identification of radiopharmaceuticals by their retention on HPLC: A caveat. The International Journal of Applied Radiation and Isotopes. 35(6). 545–545. 2 indexed citations
11.
Laufer, Peter, et al.. (1983). Determination of specific activity of radiohalide preparations (75Br, 77Br, 123I, 131I) by HPLC‐UV detection following chemical derivatization to 1‐halonaphthol‐2. Journal of Labelled Compounds and Radiopharmaceuticals. 20(11). 1305–1315. 4 indexed citations
12.
Laufer, Peter, et al.. (1983). D‐glucose derivatives labelled with 75,77Br and 123I. Journal of Labelled Compounds and Radiopharmaceuticals. 20(3). 391–415. 17 indexed citations
13.
Laufer, Peter, et al.. (1983). 75, 77Br- and 123I-analogues of d-glucose as potential tracers for glucose utilisation in heart and brain. European Journal of Nuclear Medicine and Molecular Imaging. 8(6). 237–241. 27 indexed citations
14.
Laufer, Peter, et al.. (1982). Remote control synthesis of 3-[11C]-methyl-D-glucose. The International Journal of Applied Radiation and Isotopes. 33(9). 775–776. 8 indexed citations
15.
Laufer, Peter, et al.. (1982). 75 Br- and 123 I-analogues of D-glucose as potential radiopharmaceuticals. 19. 1626–1628. 5 indexed citations
16.
Scholl, H., et al.. (1982). A potential benzodiazepine receptor-binding radiopharmaceutical for positron emission tomography: [ 75 Br]-7-bromo-1,3-dihydro-5-(2'-fluorophenyl)-1-methyl-2H-1,4-benzodiazepine-2-one ([ 75 Br]-BFB). 19. 1294–1295. 2 indexed citations
17.
Laufer, Peter, et al.. (1981). 3‐[11C]‐methyl‐D‐glucose, a potential agent for regional cerebral glucose utilization studies: Synthesis, chromatography and tissue distribution in mice. Journal of Labelled Compounds and Radiopharmaceuticals. 18(6). 855–863. 26 indexed citations
18.
Laufer, Peter, et al.. (1981). Preparation of ω‐123I‐labelled fatty acids by 123I‐for‐Br exchange: Comparison of three methods. Journal of Labelled Compounds and Radiopharmaceuticals. 18(8). 1205–1214. 12 indexed citations
19.
Laufer, Peter, et al.. (1980). Enzymatic synthesis and chromatographic purification of L‐3‐[11C]‐lactic acid via D, L‐3‐[11C]‐alanine. Journal of Labelled Compounds and Radiopharmaceuticals. 17(6). 889–894. 13 indexed citations
20.
Machulla, H.‐J., Peter Laufer, & G. Stöcklin. (1976). Radioanalytical quality control of11C,18F and123I-labelled compounds and radiopharmaceuticals. Journal of Radioanalytical and Nuclear Chemistry. 32(2). 381–400. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans Svärd Breakdown of academic impact, for papers by Per Gullberg Breakdown of academic impact, for papers by Yong‐Woon Jung Breakdown of academic impact, for papers by Annika Rimland Breakdown of academic impact, for papers by D.W. McPherson Breakdown of academic impact, for papers by Dean Jolly Breakdown of academic impact, for papers by Johan Ulin Breakdown of academic impact, for papers by Stéphane Demphel Breakdown of academic impact, for papers by Louis Tluczek Breakdown of academic impact, for papers by Milton M. Perlmutter
Rankless by CCL
2026